Andrew Janowczyk
10Patents
2h-index
15Co-inventors
47Inventor score
Filing activity: Sep 17, 2010 → Dec 7, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10528848B2 | Histomorphometric classifier to predict cardiac failure from whole-slide hematoxylin and eosin stained images | Physics | 2 | Active |
| US9111179B2 | High-throughput biomarker segmentation utilizing hierarchical normalized cuts | Physics | 2 | Active |
| US10902591B2 | Predicting pathological complete response to neoadjuvant chemotherapy from baseline breast dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) | Physics | 1 | Active |
| US11494900B2 | Prognosis of prostate cancer with computerized histomorphometric features of tumor morphology from routine hematoxylin and eosin slides | Physics | 0 | Active |
| US11983868B2 | Predicting neo-adjuvant chemotherapy response from pre-treatment breast magnetic resonance imaging using artificial intelligence and HER2 status | Physics | 0 | Active |
| US10861156B2 | Quality control for digital pathology slides | Physics | 0 | Active |
| US12412405B2 | Batch effect mitigation in digitized images | Physics | 0 | Active |
| USRE50416E1 | Quality control for digital pathology slides | General | 0 | Active |
| US11645753B2 | Deep learning-based multi-site, multi-primitive segmentation for nephropathology using renal biopsy whole slide images | Physics | 0 | Active |
| US10769783B2 | Predicting prostate cancer biochemical recurrence using combined nuclear NF-KB/P65 localization and gland morphology | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.